Loading clinical trials...
Loading clinical trials...
Active Immunotherapy of Patients With Acute Myeloid Leukemia Using Autologous Dendritic Cells Transfected With RNA Encoding Leukemia-associated Antigens
Conditions
Interventions
DC vaccination for postremission therapy in AML
Locations
1
Germany
Hospital of the University of Munich, LMU; Department od Medicine III
Munich, Germany
Start Date
November 5, 2013
Primary Completion Date
March 31, 2018
Completion Date
September 30, 2018
Last Updated
October 12, 2018
NCT06285890
NCT06220162
NCT04065399
NCT04628026
NCT06484062
NCT06994676
Lead Sponsor
Ludwig-Maximilians - University of Munich
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions